Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJpel Priv Eqty Regulatory News (JPEL)

Share Price Information for Jpel Priv Eqty (JPEL)

Share Price is delayed by 15 minutes
Get Live Data
1.24    0.00 (0.00%)
Bid:
1.20
Ask:
1.28
Spread: 0.08 (6.667%)
Market Cap: $21.21m
JPEL Live PriceLast checked at - London Stock Exchange

Intraday Jpel Priv Eqty Share Chart

Circular With Special Resolutions

23 Jul 2012 15:15

RNS Number : 2903I
J.P. Morgan Private Equity Ltd
23 July 2012
 



 

JPEL PUBLISHES CIRCULAR WITH SPECIAL RESOLUTIONS

 

* * *

 

GUERNSEY, 23 JULY 2012

 

J.P. Morgan Private Equity Limited ("JPEL" or the "Company") has today published a circular to Shareholders.

 

The circular contains notices in respect of the 2012 AGM of the Company and class meetings of holders of US$ Equity Shares and each class of ZDP Shares. The meetings will be held at 3:30 p.m. (London time) on 5 September 2012 at Carinthia House, 9 -12 The Grange, St Peter Port, Guernsey GY1 4BF.

 

Details of the resolutions proposed at each of the meetings are set out in the circular. JPEL's Board of Directors (the "Board") would like to highlight that the following special resolution will be proposed to the Company as a whole at the AGM and to each class of shareholders at the relevant class meeting:

·; Amend the limits on borrowing to 30 per. cent of the Total Assets of the Company.

·; Amend the final capital entitlement dates of each of the Company's three classes of ZDP Shares. JPEL proposes that each final capital entitlement date be moved forward by two months but that each final capital entitlement will remain the same.

·; Increase the minimum cover under the ZDP Test from 1.3 times to 2.0 times, as defined in the Company's Articles.

The implementation of the changes described above is conditional on approval of the relevant resolutions at each of the AGM and each of the class meetings.

The Board would also like to highlight the following resolution to be proposed at the US$ Equity Share Class Meeting:

·; Approve the refinancing proposal for the Company's 2013 ZDP Shares. JPEL proposes that the Company's 2013 ZDP Shares be refinanced primarily through a combination of available cash and undrawn borrowings under the existing credit facility.

 

JPEL's Board is focused on the optimisation of the Company's capital structure. The Board believes that the combination of all ordinary, special and extraordinary resolutions proposed at the meetings referred to in the circular will provide JPEL with maximum flexibility to efficiently manage its capital structure.

 

Copies of the following documents are available for inspection at the offices of Herbert Smith LLP, Exchange House, Primrose Street, London EC2A 2HS, at the registered office of the Company during normal business hours of any business day (Saturdays and public holidays excepted) until the conclusion of the class meetings referred to in the circular and at the place of the AGM for 15 minutes prior to the AGM until the conclusion of the class meetings referred to in the circular:

 

·; the current Memorandum of Incorporation and the Articles of Incorporation;

·; the proposed amendments to the Articles of Incorporation; and

·; the AGM circular.

 

Colour-coded copies of the circular and proxy form will be mailed to shareholders.

 

Copies of the circular and proxy form have been submitted to the National Storage Mechanism and will shortly be available for inspection at:

http://www.morningstar.co.uk/uk/NSM.

 

A full copy of the circular and annual report and accounts are available on JPEL's website (through http://www.jpelonline.com/investor-information/shareholder_documents/2012.aspx).

 

 

Further copies of this document may be obtained, free of charge, from the registered office of the Company and from:

 

J.P. Morgan Asset Management

20 Finsbury Street

London

EC2Y 9AQ

United Kingdom

 

J.P. Morgan Asset Management

270 Park Avenue

New York, NY 10017

USA

 

 

 

* * *

 

About J.P. Morgan Private Equity Limited

 

J.P. Morgan Private Equity Limited is a Guernsey registered and incorporated, London Stock Exchange-listed, closed-ended investment company (LSE: JPEL, JPEZ, JPZZ, JPSZ) designed primarily to invest in the global private equity market. The investment objective of the Company is to achieve both short and long-term capital appreciation by investing in a well diversified portfolio of private equity fund interests and by capitalising on the inefficiencies of the secondary private equity market. On 17 August 2009, JPEL issued warrants free of subscription cost to shareholders on record. The warrants are publicly traded on the London Stock Exchange under the symbol "JPWW."

 

END

 

For further information please contact:

 

J.P. Morgan Private Equity Limited

Troy Duncan / Greg Getschow

Troy.Duncan@jpmorgan.com / Gregory.Getschow@jpmorgan.com

 

Rosemary DeRise / Samantha Ladd

+1 212 648 2980 / +1 212 648 2982

Rosemary.DeRise@jpmorgan.com / Samantha.Ladd@jpmorgan.com

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCRJMITMBBTBIT
Date   Source Headline
18th Nov 20207:00 amRNSStatement re Company Update
13th Nov 20202:49 pmRNSNet Asset Value - August 2020
9th Nov 20204:43 pmRNSNet Asset Value - July 2020
4th Nov 20209:35 amRNS2020 AGM CIRCULAR
8th Oct 20207:00 amRNSAnnual Financial Report - 30 June 2020
16th Sep 202011:55 amRNSNet Asset Value - June 2020
31st Jul 20203:05 pmRNSNet Asset Value - May 2020
24th Jun 20207:00 amRNSNet Asset Value - April 2020
10th Jun 202011:04 amRNSNet Asset Value - March 2020
24th Apr 20207:00 amRNSNet Asset Value - February 2020
14th Apr 20204:47 pmRNSNet Asset Value - January 2020
14th Apr 20203:35 pmRNSNet Asset Value - January 2020
14th Apr 20203:16 pmRNSHolding(s) in Company
1st Apr 20205:35 pmRNSReplacement Completion of 7th Mandatory Redemption
1st Apr 20203:33 pmRNSCompletion of Seventh Mandatory Redemption
25th Mar 20207:00 amRNSSeventh Mandatory Redemption
17th Mar 20203:46 pmRNSHalf-year Report - 31 December 2019
13th Mar 20207:00 amRNSPartial Sale of 2nd Largest Investment
6th Mar 20204:51 pmRNSNet Asset Value(s) - December 2019
10th Jan 20203:21 pmRNSNet Asset Value - November 2019
5th Dec 20194:56 pmRNSNet Asset Value(s) - October 2019
26th Nov 20197:00 amRNSAGM Results 2019
15th Nov 20196:23 pmRNSNet Asset Value(s) - September - Replacement
15th Nov 20195:52 pmRNSNet Asset Value(s) - September
15th Nov 20195:51 pmRNSNet Asset Value(s) - August 2019
15th Nov 20195:51 pmRNSNet Asset Value(s) - July 2019
5th Nov 20195:42 pmRNS2019 AGM CIRCULAR
22nd Oct 20197:00 amRNSCompletion of Sixth Mandatory Redemption
9th Oct 20193:28 pmRNSSixth Mandatory Redemption
27th Sep 201910:48 amRNSAnnual Financial Report - 30 June 2019
10th Sep 20191:19 pmRNSNet Asset Value(s) - June 2019
12th Jul 20197:00 amRNSNet Asset Value(s) - May 2019
13th Jun 20197:00 amRNSNet Asset Value(s) - April 2019
17th May 20197:00 amRNSNet Asset Value(s) - March 2019
5th Apr 20197:00 amRNSNet Asset Value(s) - February 2019
19th Mar 20193:57 pmRNSHalf-year Report - 31 December 2018
13th Mar 20197:00 amRNSNet Asset Value(s)
7th Feb 201910:55 amRNSNet Asset Value(s) - December 2018
22nd Jan 201910:10 amRNSNet Asset Value(s) - November 2018
8th Jan 20197:00 amRNSCompletion Of Fifth Mandatory Redemption
10th Dec 20183:58 pmRNSMandatory Redemption - US$Equity Shares - Dec 2018
6th Dec 20183:28 pmRNSHolding(s) in Company
30th Nov 20183:21 pmRNSNet Asset Value(s) - October 2018
27th Nov 201811:08 amRNSAGM Results 2018
7th Nov 20187:00 amRNS2018 AGM CIRCULAR
30th Oct 20187:00 amRNSNet Asset Value(s) - August 2018
30th Oct 20187:00 amRNSNet Asset Value(s) - July 2018
30th Oct 20187:00 amRNSNet Asset Value(s) - September 2018
12th Oct 20184:32 pmRNSHolding(s) in Company
4th Oct 20182:42 pmRNSNotification of Dealings in Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.